LOGiKron powered by Omikron S-Core

LOGiKron is an advanced inference and knowledge-structuring engine designed to operate at the intersection of biomedical research, systems biology, and computational pharmacology.

At its core, LOGiKron does not simply retrieve information — it connects it. By processing heterogeneous datasets drawn from clinical literature, preclinical evidence, and observational records, it constructs layered, multi-resolution knowledge maps that reveal non-obvious relationships between biological targets, therapeutic agents, and disease pathways.

 

Powered by the Omikron S-Core — a modular scoring and validation architecture — LOGiKron assigns structured confidence metrics to every inference it generates, distinguishing between empirically grounded evidence, translational hypotheses, and speculative extrapolations. Each output is transparently stratified across multiple epistemic levels, from public-facing summaries to specialist-grade mechanistic detail.

LOGiKron is built for researchers, clinicians, and protocol designers who need more than a literature search — they need a reasoning partner capable of synthesizing fragmented evidence into actionable, structured hypotheses while maintaining full traceability of every logical step.

OMIKRON S-Core · Q-Leap Research Program · 2026

The Physics
of Disease.

One framework. Every scale.
Both directions.

OMIKRON S-Core is the first causal database that maps biological disease through the lens of physics — not molecular pathways, but physical operators, thermodynamic laws, and fractal invariance across scales. 19,969 curated records. Two disease domains. Seven universal laws.

Explore the Framework For Investors →
19,969 Causal records
2 Disease domains
7 Physical laws
14 Fractal patterns
91.4 Avg. evidence score

What is OMIKRON

Disease is not a
molecular accident.

"Cancer is not an alien. It is the necessary result of seven known physical laws applied to a biological system that has exceeded its operational limits."

— OMIKRON Framework Laws FL000001–FL000007

OMIKRON S-Core

S-Core is the computational engine — a database of 19,969 physically typed causal relationships, each describing not merely what causes what, but through which physical operator, at which scale, with which thermodynamic signature.

Every record carries three evidence levels (L0 public · L1 medical · L2 specialist), a verified DOI, a Score and a Consensus index calibrated on literature. Average evidence score: 91.4 out of 100.

S-Core is not a literature summary. It is a structured physical argument about disease — expressed as a graph, queryable as a database, falsifiable as a scientific theory.

The OMIKRON Framework (OF)

OF is the theoretical architecture that gives S-Core its meaning. Six physical laws — forced oscillator dynamics, thermodynamics, mechanobiology, biochemistry as parameter modulation, fluid dynamics, and phase transitions — unified by a seventh: fractal invariance and the renormalization group.

Every record maps to at least one law. Every fractal record (FR) documents where the same physical pattern replicates across molecular, cellular, and systemic scale with a measurable scaling ratio λ.

The framework predicts drug transferability cross-context: IC50B = IC50A × (λB/λA). The tissue-agnostic approval of pembrolizumab for MSI-H tumors is the clinical proof of this principle already in clinical use.

Seven Laws

The physics that
governs disease.

Every tumor, every neurodegeneration, every systemic collapse — describable through equations already in the physics textbook.

FL000001 · FDO
Forced Damped Oscillator
m·ẍ + c·ẋ + kx = F(t)
κ = λc / √(Kecm · Kq)
The tumor is the divergent state of a biological oscillator that has lost its damping coefficient c. κ quantifies physical drug resistance independently of molecular targets — measurable from a biopsy in 4 weeks.
FL000002 · THERMODYNAMICS
Second Law & Systemic Entropy
dS_ER/dt = P_trans + M_misfold − C_UPR − J_autophagy
Desmoplasia is an alternative energy minimum — not disorder. Triple Notch Therapy forces the cancer cell toward a proteotoxic singularity by zeroing all damping terms simultaneously.
FL000003 · MECHANOBIOLOGY
Stiffness as Signal
LSI = L_stroma × Kecm / f_collagenI
D_frac ∈ [1.0, 2.0]
ECM stiffness above 8 kPa physically excludes immune cells and antibodies. D_frac > 1.75 predicts 10-year survival with HR = 2.6. Better than histological grade. Measurable in 10 minutes.
FL000004 · BIOCHEMISTRY
Biochemistry as Physical Parameters
ERO1A↑ → Kecm↑ | KRAS → F(t)↑
GPX4 = c_ferroptosis
Every enzyme modifies a physical parameter at molecular scale. The renormalization group makes drug transferability across tumor contexts mathematically necessary — not empirical.
FL000005 · FLUID DYNAMICS
Interstitial Pressure & Ionic Uptake
Jv = Lp·(ΔP − σ·Δπ)
Na⁺/K⁺ ratio → Kq
IFP 20–100 mmHg in tumors vs 0–3 mmHg in normal tissue physically excludes antibodies. The same potassium ion modulates G-quadruplex conformation and nephron synchronization at two different scales.
FL000006 · PHASE TRANSITIONS
Unjamming & Epithelial Phase
p₀ = perimeter / √area
p₀ < 3.81 → jammed | p₀ > 3.81 → invasion
Metastatic invasion is a first-order phase transition. The AVB axis collapse triggers p₀ > 3.81 — tissue melts. Measurable from a standard H&E slide. Preventable with t-VNS protocol.
FL000007 · FRACTAL RENORMALIZATION GROUP — the unifier
Scale Invariance across all laws
OP[A / low_scale] ~ OP[B / high_scale] | k_n / k_{n+1} ≈ constant → IC50_B = IC50_A × (λB / λA)
If the same physical operator governs a process at molecular and systemic scale with a constant ratio between parameters, the system is fractal. 14 fractal patterns identified in the database, each with a measurable scaling ratio λ and a cross-context drug transferability prediction. The tissue-agnostic approval of pembrolizumab for MSI-H tumors is the clinical proof of this principle.

The Omikron Framework

ON · OR · HS · XD
Oncology. Or Rare Disease.

Four dataset types sharing one physical grammar. Each activates or deactivates independently. Query across both domains to find the bifurcation point where the same biological collapse chooses proliferation or degeneration.

ON
Oncology
17,380
OF000001 – OF017401
Cancer pathways, synthetic lethality, immunotherapy, desmoplasia, metabolic reprogramming. 902 distinct tumor types. Score avg 91.9.
OR
Orphan & Rare
2,568
OF017402 – OF019969
Neurodegeneration, rare genetic disorders, proteopathies, systemic sclerosis. Alzheimer, Parkinson, ALS, Huntington and 946 more disease types.
XD
Cross Domain
21
FR + FL · universal
Fractal patterns and framework laws — universal by physical definition. Each XD record applies to both ON and OR simultaneously with a measurable scaling ratio λ.
HS
Healthy System
—
Coming next
The physiological baseline — what the healthy oscillator looks like before the damping collapses. The reference state against which both ON and OR are precisely measured.

40 Dataset Contexts — semantic vocabulary

AXCPKX TXCXDX NXVXQX MXHXFX SXLXWX BXGXSH IBEB BB·ORFP·ORPP OXDX·ORVX·OR FRFLXD

■ ON · Oncology   ■ OR · Orphan & Rare   ■ XD · Cross Domain

Physical Operators

21 operators.
One grammar.

Every record uses exactly one OP_Code — a physical operator specifying the type of causal relationship. 8 new operators introduced by the OR dataset describe processes absent in oncology: progressive resource exhaustion, kinetic trapping, virtual domain coupling.

K-SYNC
Kinetic synchronization across scales
5,346 records
K-STALL
Kinetic arrest — activation barrier increase
4,441 records
K-START
Kinetic forcing — proliferative signal onset
4,298 records
K-PUSH
Gradient-driven kinetic forcing
1,067 records
K-FLOW
Inhibitory flux propagation
1,020 records
K-SHIFT
Kinetic regime shift
670 records
K-BREAK
Threshold crossing — discontinuous transition
269 records
C-DAMP
Damping collapse — shock absorber failure
113 records
T-DRAIN
Resource exhaustion over time
506 records · OR only
T-START
Exhaustion process initiation
218 records · OR only
V-LINK
Virtual domain coupling — neural signaling
259 records · OR only
K-TRAP
Kinetic trap — irreversible state
58 records · OR only
RESOURCE_EXHAUSTION
System-level resource depletion
122 records · OR only
Q-START
Quantum-step process initiation
33 records · OR only
MAP
Structural mapping of causal relationship
361 records
CHECK
Evidence validation checkpoint
544 records

■ New operators introduced by OR dataset — not present in oncology

The Central Discovery

Why does the same collapse
choose proliferation
or degeneration?

The database now contains both directions of disease. The bifurcation emerges from the topology — not from molecular biology, but from which physical domain collapses first and which tissue stiffness k the system inhabits.

→ Oncology (ON)
The system maintains genomic self-reference. BIO_GENETIC → BIO_GENETIC has 709 arcs in ON, zero in OR. The cancer amplifies through its own molecular domain. High stiffness ECM (k ↑) creates a selective environment for proliferating cells.
k high → ECM stiffness → proliferative selection
BIO_GENETIC self-loops: 709 arcs (ON only)
KINETICS → KINETICS dominant pattern
Desmoplasia = ordered energy minimum
SAME
FORCING
F(t) ⟷ k decides
→ Degeneration (OR)
The system collapses through network feedback. CYBERNETICS and STAT_MECH dominate. The disease propagates through statistical accumulation in soft tissue (k ↓). Cells exhaust and die progressively instead of proliferating.
k low → soft tissue → no proliferative selection
CYBERNETICS: 725 arcs OR vs 6,108 ON
STAT_MECH ratio OR/ON = 0.42 (highest)
T-DRAIN — progressive resource exhaustion

"The disease does not choose proliferation or degeneration. The tissue chooses — through its physical stiffness k. Hard tissue amplifies. Soft tissue exhausts. The same forcing, two destinations."

— OMIKRON Framework · Bifurcation Hypothesis · 2026

Domain Topology

CYBERNETICS is the
bridge that cannot fall.

Graph analysis of 19,969 records identifies a single critical bridge node, two structural gaps between domains, and three cross-disease records needed to complete the unified topology.

Bridge Node · Critical
CYBERNETICS
6,834 arcs · ON + OR
Removing CYBERNETICS disconnects the domain graph into three separate components. It corresponds to the autonomic nervous system, AVB axis, and systemic feedback — the topological prerequisite for both cancer and neurodegeneration. This is why AVB collapse is not a side effect but the structural precondition.
Structural Gap · Critical
BIO_GENETIC
absent in OR — 709 arcs missing
Cancer self-amplifies at the genomic level (BIO_GENETIC → BIO_GENETIC, 709 ON arcs, 0 OR). Neurodegeneration does not. This asymmetry is the physical signature of the bifurcation. Cross-disease XD records bridging this gap will map the exact conditions under which genomic self-reference activates versus network exhaustion dominates.
New Frontier · XD Records
VIRTUAL_DOMAIN
14 OR-only arcs
CYBERNETICS → VIRTUAL_DOMAIN → FLUID_DYNAMICS describes neural signal propagation through cerebrospinal fluid — a physical process with no oncological equivalent. These 14 records are the seed of the HS (Healthy System) dataset: the physics of the brain in homeostasis, the reference state against which neurodegeneration is measured.

For Investors & Partners

A new coordinate
system for disease.

⚗
FR Scaling Therapeutics
The first mathematically rigorous method to predict drug transferability across tumor contexts using fractal scaling ratios. IC50B = IC50A × (λB/λA). Reduces preclinical failures by predicting which drugs work in context B before the experiment is run.
🔬
OMIKRON Diagnostic Triad
Three measurable parameters — HRV, zonulin, NLR/LBP — capturing the physical state of the biological oscillator. Predictive of immunotherapy response, disease progression, metastatic timing. Measurable with existing clinical instruments at minimal cost.
⚡
κ — Physical Drug Resistance Index
Companion diagnostic for immunotherapy in desmoplastic tumors. κ > 1.0 predicts pembrolizumab resistance in PDAC with HR ≥ 1.5. Measurable from a fresh biopsy in 4 weeks. Targets the $4B annual cost of checkpoint inhibitor non-response.
🧬
Cross-Disease Intelligence
The only database mapping both oncology and rare/orphan diseases through the same physical grammar. Cross-domain queries reveal bifurcation nodes — targets that shift a system between proliferative and degenerative trajectories.

Development Roadmap

Phase 0
Now
IP Protection & Retrospective Validation
UIBM copyright deposit. Retrospective study n=200–300 (IRCCS): OMIKRON Triad as predictor of immunotherapy response. Budget < €15,000. Target: IRCCS Regina Elena · INT Milano · IEO.
Phase 1
6–18 mo
Interventional Pilot RCT
n=60 · t-VNS + Akkermansia vs placebo · 8 weeks pre-immunotherapy. Primary: OMIKRON Triad normalization. Secondary: ORR at 6 months. Budget €80–120k.
Phase 2
18–36 mo
κ Validation & XD Bridge Records
Prospective κ measurement in PDAC biopsies. Cross-disease XD record construction. HS dataset launch. First SaMD regulatory submission.
Phase 3
36+ mo
Software as Medical Device
CE Class IIa SaMD: OMIKRON algorithm for immunotherapy candidate selection. Partnership target: SYNLAB · bioMérieux · Roche Diagnostics. Licensing of FR Scaling Therapeutics to pharma.

Contact

Ready to explore
the physics of disease?

OMIKRON S-Core is available for research partnerships, licensing discussions, and clinical collaboration. Every prediction in the framework is falsifiable.

Get in Touch
© 2026 Giorgio Modesti · All rights reserved · Pre-IP deposit confidential
DISCLAIMER: The OMIKRON Framework and S-Core database are research tools in active development. All clinical predictions are scientific hypotheses requiring prospective validation. Not approved for diagnostic or therapeutic use. Not for public distribution prior to IP deposit. Evidence scores reflect literature-based curation; they do not constitute regulatory or clinical validation of any kind.